Type III IFNs: new layers of complexity in innate antiviral immunity.
about
Dendritic cells in human Pneumovirus and Metapneumovirus infectionsComparison of antiviral activity of lambda-interferons against HIV replication in macrophagesIFN-λ: A New Inducer of Local Immunity against Cancer and InfectionsInhaled innate immune ligands to prevent pneumonia.The viral nucleoprotein determines Mx sensitivity of influenza A viruses.Interaction between innate immunity and porcine reproductive and respiratory syndrome virus.Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsInduction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells.Dendritic Cell-Airway Epithelial Cell Cross-Talk Changes with Age and Contributes to Chronic Lung Inflammatory Diseases in the ElderlyInnate immune recognition and activation during HIV infection.Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto.IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.The airway epithelium: soldier in the fight against respiratory virusesInterferon in the treatment of chronic hepatitis C: a drug caught between past and future.Bioactivity determination of native and variant forms of therapeutic interferons.Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysisType III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunityIL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesIdentification, Characterization, and Developmental Expression Pattern of Type III Interferon Receptor Gene in the Chinese Goose.Inducible innate resistance of lung epithelium to infection.Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye DiseaseInterferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytesCritical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo.Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.Impaired secretion of interferons by dendritic cells from aged subjects to influenza : role of histone modifications.Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.The IL-28 genotype: how it will affect the care of patients with hepatitis C virus infection.HBV life cycle and novel drug targets.Buying time-the immune system determinants of the incubation period to respiratory viruses.Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia.Upper airway stem cells: understanding the nose and role for future cell therapy.
P2860
Q26865337-AF50FD0E-C81B-488F-B17A-3FF01F750473Q27307732-1D2EF0F0-5596-430A-BB7D-6F196A4EEC62Q28072995-E8F0462F-3616-4690-BD47-1B2130261D17Q30398752-F9AA176A-FB3E-4336-BA5E-AAC90ED15001Q30403933-F625742A-E393-48AD-B6D4-DEB66C5D3383Q30410415-E0B19847-2DD4-4F89-B4CD-9A4727D483BAQ30499869-1510D215-383F-4CBC-A10E-ED8F22265F71Q30683907-E954CA91-227C-4C98-B512-266C87D3A122Q33525565-AD8EA4F5-21BD-4FFE-9657-B03033A8C7EAQ33612256-7B88FD64-D895-4487-9F96-3F55BCA51C42Q33838704-8D38C539-8C1D-4C46-BFC8-1685EBF3E271Q33997880-18C27C58-A01E-4A46-A1DF-E9EA067EDA63Q34043150-8553D4C0-F6F3-418C-A631-6F11A798566DQ34147632-F15331B3-EA73-44A3-8B21-4188F9BDC2D9Q34256897-35109B9C-940D-49F4-B2A1-B200D9D151DDQ34294746-87AA8BAA-8BEF-440A-B97A-6E86483036D8Q34491598-859FB96A-7B51-44E0-BACF-B56FE70E1FFDQ34626479-AEE54DCF-BE3E-4FAC-85CF-B7B1015CEC99Q34635157-6099E978-940B-40F0-BA93-BD6448326370Q34653087-D1D5A8E7-6C8E-4D1A-9F85-8A75C81BB96CQ34676626-14BA3996-6F9F-4759-BB91-05BCE8BD2B23Q34744565-A20F7C42-5C6E-4EB6-8BAD-961C8324CE60Q35208006-1C65C998-ED59-4524-BD76-8CBDF5BC2BD4Q35590991-8501E686-DAB3-4A14-997F-08417936F3DDQ35639482-7ACE60A6-D002-4686-BC96-96F84EDE8D10Q35754472-B73D0300-9C44-4D2B-AFF9-94FC05AF405BQ35773063-0FD0C9DB-9FC2-4474-B0B1-06C095902DC3Q35865362-17024BE8-07A0-4B05-88AB-9B1B2EE37F44Q36138293-57128186-F5E2-40C7-AB51-DC652367E756Q36559518-6875D3E8-9456-44C0-ADD2-A4691FF0E8F1Q36630086-5510D81A-2AC1-4D4D-B60A-503B4B512DF4Q36890411-45A194CB-EF26-4E07-9E96-EDCE53051E36Q37179927-C1D3020D-9A89-45D4-9CD7-7173D710AE4BQ37604941-104C2A79-CD95-4734-8141-CC3B6886A17CQ37681541-BF33FF8A-2A5F-4236-BBFD-FE3444544EBEQ37809806-D23967F2-1899-43C8-A906-0E70D77345DEQ37864117-AD08AE96-5D78-41E4-B6B1-AE3CFA45716DQ37945196-B0BD7403-A5B6-4715-93CE-F60872A08B00Q38008395-5F9BD300-E2D5-4D39-AE82-4E0ACA785852Q38272205-7EA6C1A0-074C-4317-92A1-C98E0963E0AA
P2860
Type III IFNs: new layers of complexity in innate antiviral immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type III IFNs: new layers of complexity in innate antiviral immunity.
@en
Type III IFNs: new layers of complexity in innate antiviral immunity.
@nl
type
label
Type III IFNs: new layers of complexity in innate antiviral immunity.
@en
Type III IFNs: new layers of complexity in innate antiviral immunity.
@nl
prefLabel
Type III IFNs: new layers of complexity in innate antiviral immunity.
@en
Type III IFNs: new layers of complexity in innate antiviral immunity.
@nl
P2860
P356
P1433
P1476
Type III IFNs: new layers of complexity in innate antiviral immunity.
@en
P2093
Søren R Paludan
P2860
P356
10.1002/BIOF.19
P577
2009-01-01T00:00:00Z